Invesco Ltd. Veracyte, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 322,526 shares of VCYT stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

322,526

Previous 411,777 21.67%

Holding current value

$11.6 Million

Previous $8.92 Million 23.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$21.0 - $35.25 $1.87 Million - $3.15 Million	-89,251 Reduced 21.67%	322,526 $11 Million
Q2 2024 Aug 13, 2024	BUY	$18.86 - $23.55 $1.01 Million - $1.26 Million	53,403 Added 14.9%	411,777 $8.92 Million
Q1 2024 May 14, 2024	BUY	$21.0 - $29.1 $609,630 - $844,773	29,030 Added 8.81%	358,374 $7.94 Million
Q4 2023 Feb 12, 2024	SELL	$19.72 - $28.68 $2.9 Million - $4.22 Million	-147,005 Reduced 30.86%	329,344 $9.06 Million
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $2.95 Million - $3.96 Million	132,310 Added 38.46%	476,349 $10.6 Million
Q2 2023 Aug 11, 2023	SELL	$20.96 - $26.99 $944,373 - $1.22 Million	-45,056 Reduced 11.58%	344,039 $8.76 Million
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $1.55 Million - $2.1 Million	75,121 Added 23.93%	389,095 $8.68 Million
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $1.51 Million - $2.95 Million	-98,670 Reduced 23.91%	313,974 $7.45 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $58.4 Million - $98.3 Million	-3,525,022 Reduced 89.52%	412,644 $6.85 Million
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $3 Million - $5.72 Million	-193,931 Reduced 4.69%	3,937,666 $78.4 Million
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $385,398 - $746,730	17,566 Added 0.43%	4,131,597 $114 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $6.55 Million - $9.76 Million	181,381 Added 4.61%	4,114,031 $169 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $11.2 Million - $16.6 Million	-313,920 Reduced 7.39%	3,932,650 $183 Million
Q2 2021 Aug 17, 2021	BUY	$32.94 - $56.62 $1.89 Million - $3.24 Million	57,275 Added 1.37%	4,246,570 $170 Million
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $27.6 Million - $50.6 Million	621,710 Added 17.43%	4,189,295 $225 Million
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $2.05 Million - $3.91 Million	-63,144 Reduced 1.74%	3,567,585 $175 Million
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $11.3 Million - $15 Million	421,552 Added 13.14%	3,630,729 $118 Million
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $260,912 - $376,308	-13,387 Reduced 0.42%	3,209,177 $83.1 Million
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $1.86 Million - $3.48 Million	-115,325 Reduced 3.46%	3,222,564 $78.3 Million
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $2.37 Million - $3.42 Million	114,182 Added 3.54%	3,337,889 $93.2 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $5.68 Million - $7.36 Million	237,962 Added 7.97%	3,223,707 $77.4 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $52.8 Million - $68.3 Million	2,390,394 Added 401.51%	2,985,745 $85.1 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $5.78 Million - $12.4 Million	481,594 Added 423.35%	595,351 $14.9 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $1.04 Million - $1.69 Million	113,757 New	113,757 $1.43 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.57B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account